Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: Facing a crossroad?

被引：0
|
作者：
Alexopoulos, Dimitrios [1 ]
机构：
[1] Patras Univ Hosp, Dept Cardiol, Patras 26500, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 01期
关键词：
Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Reloading; CHRONIC CLOPIDOGREL THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ANTIPLATELET THERAPY; PLATELET INHIBITION; ANGIOPLASTY; TICAGRELOR; PRASUGREL;
D O I：
10.1016/j.ijcard.2012.09.202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：292 / 293
页数：2
相关论文
共 50 条
  • [31] Effect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular Events
    Girotra, Saket
    Stebbins, Amanda
    Wruck, Lisa M.
    Riley, Danielle
    Kripalani, Sunil
    Munoz, Daniel
    Effron, Mark B.
    Gupta, Kamal
    Whittle, Jeffrey
    Benziger, Catherine
    Zhou, Li
    Farrehi, Peter M.
    Polonsky, Tamar S.
    Ahmad, Faraz S.
    Roe, Matthew T.
    Rothman, Russell
    Harrington, Robert A.
    Hernandez, Adrian F.
    Jones, William S.
    CIRCULATION, 2022, 146
  • [32] Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence
    Ouyang, Chenxi
    Meng, Changjiang
    Li, Fei
    Nie, Shanshan
    Gong, Liying
    Cao, Yu
    Yuan, Hong
    Feng, Zeying
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1811 - 1819
  • [33] P2Y12 inhibitors - Thienopyridines and direct oral inhibitors
    Collet, J. -P.
    Montalescot, G.
    HAMOSTASEOLOGIE, 2009, 29 (04): : 339 - +
  • [34] Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI
    Ayoub, Ali
    Ayinapudi, Karnika
    Al-Ogaili, Ahmed
    Panhwar, Muhammad Siyab
    Dakkak, Wael
    LeJemtel, Thierry
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (02) : 153 - 163
  • [35] In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin plus clopidogrel reduced adverse events
    Lowenstern, Angela
    Newby, L. Kristin
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (06) : JC28 - JC28
  • [36] Comparing loading strategies of P2Y12 inhibitors in patients undergoing elective PCI: a network meta-analysis
    Gupta, R.
    Malik, A.
    Vadhar, S.
    Briasoulis, A.
    Vyas, A.
    Patel, N.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1210 - 1210
  • [37] Effect of P2Y12 inhibitors on inflammation and immunity
    Thomas, Mark R.
    Storey, Robert F.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (03) : 490 - 497
  • [38] Potent P2Y12 Inhibitors and Bleeding Complications
    Guner, Ahmet
    Guner, Ezgi Gultekin
    Kahraman, Serkan
    Uzun, Fatih
    Erturk, Mehmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (07): : 543 - 544
  • [39] The use of P2Y12 inhibitors in ACS patients with culprit lesion of left main disease in China: findings from the CCC-ACS Project
    Zhao, Guanqi
    Liu, Jing
    Yang, Na
    Fonarow, Gregg C.
    Ge, Junbo
    Taubert, Kathryn A.
    Morgan, Louise
    Ma, Changsheng
    Zhao, Dong
    Han, Yaling
    Smith, Sidney C., Jr.
    Huo, Yong
    Nie, Shaoping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C108 - C108
  • [40] P2Y12 INHIBITION IN ACS: PLATELET AND BEYOND PLATELET EFFECTS
    Badimon, L.
    Mendieta, G.
    Casani, L.
    Vilahur, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 23 - 23
12345